💼✨ Our team had an incredible time at the International Clinical Trials Methodology Conference (#ICTMC2024) in Edinburgh! 🏴
A big thank you to the organizers and everyone we had the chance to meet and collaborate with! 🙌
Here are some moments from the conference 📸👇
Jennifer Brown, Nadine Tschumi and Niklaus Labhardt from the #ClinEpi with Roger Kouyos from the Universitätsspital Zürich received a @snf_ch Project Grant to explore dynamics and predictors of #HIV#Dolutegravir resistance in Southern Africa.
Excellent introduction to Trials Within Cohort (TWiCs) designs from Christof Schoenenberger at #ICTMC2024. Useful summary paper here …
https://t.co/ZvbidM9v1V
New article!📣
We provide an overview on existing trials using the TwiCs (Trials within Cohorts) design and summarise characteristics, used consent patterns and challenges of the trials using the TwiCs design.
Check out:
https://t.co/A3dJr1oczo
Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function
@AlAinAmstutz @BenjaminSpeich @JIDJournal
Read here the full COVERALL-3 study:
https://t.co/lURexiqAlT
Strong presence of @ClinEpiBasel (Felix Gerber/@schonenberger_c) at the #TwiCs2023 symposium (https://t.co/t1x3e21vVf). Exciting to share lessons learnt from #combacal@SolidarMed and #shcs with an international audience (> 80 participants) and learn from others in the field🌍
Kudos to Manina Etter and Kevin Akeret 🏆 winners of the 2023 Aesculap - EANS Research Prize for Best Clinical & Laboratory Paper, respectively! THANK YOU to @bbraun_com Aesculap for awarding each researcher with a Research Prize of 5,000 #EANSonline https://t.co/MtOxFozFdR
The National MD-PhD Commission has selected 15 young research-oriented physicians. They will be supported in obtaining their PhD with a two to three year grant.
https://t.co/t8NPpzV8nU
Primary results of two randomized trials conducted at journal level: Asking peer reviewers to check if reporting items are adequately reported did not lead to an improvement in the reporting quality in published articles.
https://t.co/6SVn5kmcrY
@BenjaminSpeich
The COVERALL2 trial showed the non-inferiority in antibody response of the third #Moderna vaccine dose compared to the third Pfizer-BioNTech vaccine, in #PLHIV and solid organ transplant recipients.
Congratulations @AlexandraGries2 and @BenjaminSpeich
https://t.co/eTUJqHoH3H
Verlust von Geruchs- und Geschmacksinn, #brainfog, schlimmstenfalls sogar Schlaganfälle: Forschende @unibasel & @unispitalbasel haben Mechanismen hinter Neuro-#Covid aufgeklärt und Ansatzpunkte identifiziert, wie es sich verhindern liesse. https://t.co/TCbqUon4im
Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study https://t.co/O4ssCdQcjI